{"pub": "investing.com", "url": "https://ph.investing.com/news/stock-market-news/newsbreak-carcinogen-found-in-heartburn-drug-zantac-report-51085", "downloaded_at": "2019-09-13 18:42:56.877685+00:00", "title": "NewsBreak: Carcinogen Found in Heartburn Drug Zantac: Report", "language": "en", "text": "NewsBreak: Carcinogen Found in Heartburn Drug Zantac: Report\n\nStock Markets 4 hours ago (Sep 13, 2019 22:09)\n\n\u00a9 Reuters. Investing.com - U.S. and European health officials are investigating big-selling heartburn treatment Zantac and generics of the drug after a carcinogen was discovered, Bloomberg reported Friday. The drug ranitidine, branded as Zantac, was found to contain levels of a probable carcinogen in testing by an online pharmacy, according to the report. The same contaminant prompted a recall of blood-pressure pills last year. Sanofi (PA: ), the maker of Zantac, fell 0.8% in Paris trading. Its ADRs (NASDAQ: ) lost 0.3%.\n\nNewsBreak: Carcinogen Found in Heartburn Drug Zantac: Report", "description": "NewsBreak: Carcinogen Found in Heartburn Drug Zantac: Report", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEE7M0VV_L.jpg", "published_at": "2019-09-13"}